(Date:11/18/2009)...18 Marrone Bio Innovations (MBI), ...ialization of effective and environmentally respon...has been named an IC20 company by the Investors, C...nal angel investing group. ,, Companies named t...ng results for all stakeholders, including investo...
(Date:11/18/2009)...sity Belfast are developing new sensors to detect ...in the fight against the threat of terrorist attac...swipe, an individual or crime scene to gather a sa...nt that can detect the presence of chemicals withi...s to be made in response to terrorist threats. ,...
(Date:11/18/2009)...t Sussex, U.K. and CLEVELAND, Nov. 18 /PRNewswire/...s business and premier provider of diagnostic syst...abs, has expanded its East Grinstead, U.K., manufa...eet increasing global demand for its Sensititre...tion testing. The expanded facility has been fully...
(Date:11/18/2009)...la., Nov. 18 Algenol Biofuels LLC,... and the technology group The Linde Group have a...t in order to identify the optimum management of c...unique algae and photobioreactor technology. This ...develop cost-efficient technologies that capture, ...
Breaking Biology Technology:Marrone Bio Innovations Named an IC20 Company 2New technology detects chemical weapons in seconds 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 2Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 3...April 23 Keryx Biopharmaceuticals, Inc. (Nasdaq: ...l P. Tarnok to be its interim Chairman and Chief E...ctive immediately. , , Mr. Tarnok, age 54, has ...er 2007. Mr. Tarnok spent the majority of his car...ance Director -- US Manufacturing. From 2000-2007...
...rter of Consecutive Growth in Clinical Reagents; U...f., April 23 Cepheid (Nasdaq: CPHD ) today repo...8 million. Net loss was $7.4 million, or $(0.13) ...ion and a net loss of $1.9 million, or $(0.03) per...Excluding amortization of purchased intangible ass...
....J., April 23 Wyeth (NYSE: WYE ) announced toda... $2 Convertible Preferred Stock, par value $2.50 p...tive on July 15, 2009 (the "Redemption Date"). As...vertible Preferred Stock outstanding. , , The red...red Stock is $60.08, which includes an amount equa...
Other Biology Technology:Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer 2Cepheid Reports 2009 First Quarter Results 2Cepheid Reports 2009 First Quarter Results 3Cepheid Reports 2009 First Quarter Results 4Cepheid Reports 2009 First Quarter Results 5Cepheid Reports 2009 First Quarter Results 6Cepheid Reports 2009 First Quarter Results 7Cepheid Reports 2009 First Quarter Results 8Cepheid Reports 2009 First Quarter Results 9Cepheid Reports 2009 First Quarter Results 10Cepheid Reports 2009 First Quarter Results 11Cepheid Reports 2009 First Quarter Results 12Cepheid Reports 2009 First Quarter Results 13Cepheid Reports 2009 First Quarter Results 14Cepheid Reports 2009 First Quarter Results 15Wyeth Announces Full Redemption of $2 Convertible Preferred Stock 2Wyeth Announces Full Redemption of $2 Convertible Preferred Stock 3Wyeth Announces Full Redemption of $2 Convertible Preferred Stock 4Wyeth Announces Full Redemption of $2 Convertible Preferred Stock 5Anti-Mouse Ameloblastin Affinity Purified Polyclonal Antibody, Biotin Conjugated from R&D Systems
Rabbit Anti-GRASP1 Polyclonal Antibody, Unconjugated from Abcam
Rat Plasmin from Pel-Freez Biologicals
Mouse Anti-Human VEGF R3 / Flt-4 Monoclonal Antibody, Phycoerythrin Conjugated, Clone 54733 from R&D Systems
Biology Products: